Alterity Therapeutics Limited (ASX:ATH)
0.0090
+0.0010 (12.50%)
Mar 31, 2026, 4:10 PM AEST
Alterity Therapeutics Market Cap
Alterity Therapeutics has a market cap or net worth of 97.88 million as of March 31, 2026. Its market cap has increased by 47.03% in one year.
Market Cap
97.88M
Enterprise Value
48.78M
Revenue
6.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since March 28, 2000, Alterity Therapeutics's market cap has increased from 51.51M to 97.88M, an increase of 90.02%. That is a compound annual growth rate of 2.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 87.00M | - |
| Dec 31, 2025 | 87.00M | 104.41% |
| Dec 31, 2024 | 42.56M | 116.97% |
| Dec 29, 2023 | 19.62M | -18.82% |
| Dec 30, 2022 | 24.16M | -52.19% |
| Dec 31, 2021 | 50.54M | -19.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinogen Medical | 125.70M |
| Amplia Therapeutics | 125.70M |
| Paradigm Biopharmaceuticals | 113.45M |
| Island Pharmaceuticals | 109.32M |
| Botanix Pharmaceuticals | 90.94M |
| Arovella Therapeutics | 84.50M |
| LTR Pharma | 72.71M |
| Cynata Therapeutics | 71.24M |